Sign inJoin waitlistJoin the waitlist

EA

Elia Acevedo-Diaz

Principal Investigator · Clinical Center at the National Institutes of Health

Credentials: · · · ·

History

Clinical Center at the National Institutes of Health
Present

Psychiatry
2013–2017
Doctor of Medicine
2009–2013

Research

Comprehensive assessment of side effects associated with a single dose of ketamine in treatment-resistant depression
Journal of Affective Disorders · 2020 · First of 7 authors · Corresponding · 89 citations
The influence of ketamine on drug discovery in depression
Review · Drug Discovery Today · 2019 · 56 citations
Comparative metabolomic analysis in plasma and cerebrospinal fluid of humans and in plasma and brain of mice following antidepressant-dose ketamine administration
Translational Psychiatry · 2022 · 28 citations

BK
Bashkim Kadriu
6 papers
Carlos Zarate
6 papers
Grace Cavanaugh
4 papers
Luigi Ferrucci
2 papers
Mani Yavi
2 papers
JE
Josephine Egan
1 paper
RM
Rachel Meyen
1 paper · 1 as a resident
RL
Robert Litman
1 paper
SR
Sparsha Reddy
1 paper

Clinical trials

A Study of LTX-001 In Adult Participants With Acute Exacerbation of Schizophrenia
Site PI · Recruiting · Phase 1
Leal Therapeutics, Inc
2026–2027
An 8-week Open-label Study of an Accelerated and Slower Switching to Xanomeline/Trospium Following Atypical Antipsychotic Treatment in Participants With Schizophrenia
Sub-investigator · Not yet recruiting · Phase 4
Collaborative Neuroscience Research, LLC
2025